NCT03225157View on ClinicalTrials.gov

Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

November 3, 2017

Primary Completion Date

February 28, 2020

Study Completion Date

February 28, 2020

Conditions
Head and Neck NeoplasmsHearing DisorderHyperlipidemia
Trial Locations (2)

20814

Johns Hopkins Suburban Hospital, Bethesda

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

NCT03225157 - Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation | Biotech Hunter | Biotech Hunter